Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
EphA2 receptor antagonist
DRUG CLASS:
EphA2 receptor antagonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
dasatinib (215)
ALW-II-41-27 (2)
BCY6033 (1)
BT5528 (0)
BT7455 (0)
GLPG 1790 (0)
SL-701 (0)
MM-310 (0)
dasatinib (215)
ALW-II-41-27 (2)
BCY6033 (1)
BT5528 (0)
BT7455 (0)
GLPG 1790 (0)
SL-701 (0)
MM-310 (0)
›
Associations
(218)
News
Trials
VERI cancer hierarchy
Reset Filters
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
BCR-ABL1 fusion
Acute Lymphocytic Leukemia
BCR-ABL1 fusion
Acute Lymphocytic Leukemia
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 F317I
Acute Lymphocytic Leukemia
BCR-ABL1 F317I
Acute Lymphocytic Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 T315I
Acute Lymphocytic Leukemia
BCR-ABL1 T315I
Acute Lymphocytic Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
ABL2 fusion
Childhood B Acute Lymphoblastic Leukemia
ABL2 fusion
Childhood B Acute Lymphoblastic Leukemia
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
No biomarker
Chordoma
No biomarker
Chordoma
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
BCR-ABL1 F317L
Chronic Myeloid Leukemia
BCR-ABL1 F317L
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
PDGFRA D842V
Gastrointestinal Stromal Tumor
PDGFRA D842V
Gastrointestinal Stromal Tumor
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.